Fig. 7: Type III interferon and IgA signatures on Post COVID-19 condition. | Nature Communications

Fig. 7: Type III interferon and IgA signatures on Post COVID-19 condition.

From: Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8+β7 integrin+ T cells and anti-SARS-CoV-2 IgA response

Fig. 7

Quantification of the anti-N (A) and anti-S (B) IgA, IgM and IgG response after SARS-CoV-2 infection divided by individuals that developed (n = 62) or not PASC (n = 65) six months after acute disease. Quantification of anti-N (C) and anti-S IgA (D) at six months after SARS-CoV-2 infection on non-PASC (n = 65) and PASC (n = 62) individuals divided by the severity of acute disease. Spearman’s correlation between the percentage of Anti-N IgA (E) or anti-S IgA (F) and IFN-λ2/3 for non-PASC and PASC individuals. Data are shown in a scatter dot plot format as median ± IQR; Mann Whitney test and a two-way ANOVA were applied, respectively, to figures A, B and C, D.

Back to article page